The Business Times

Pfizer, Moderna testing their vaccines against UK coronavirus variant

Published Tue, Dec 22, 2020 · 11:35 AM

[WASHINGTON] Pfizer and Moderna are testing their Covid-19 vaccines against the new fast-spreading version of the virus that has emerged in Britain, CNN reported on Tuesday.

Moderna expects immunity from its vaccine to protect against the variants and is performing more tests in the coming weeks to confirm, the company said in a statement to CNN.

Pfizer said it is "generating data" on how well blood samples from people immunised with its vaccine "may be able to neutralise the new strain from the UK," according to the report.

Pfizer and Moderna did not immediately respond to Reuters' requests for comment.

The discovery of the new strain sowed a fresh wave of panic in a pandemic that has killed about 1.7 million people and infected more than 77.15 million worldwide.

The main worry is that the new variant is 40 per cent-70 per cent more transmissible.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

Scientists have said there's no evidence that vaccines currently being deployed in the United Kingdom - made by Pfizer and BioNTech - or other Covid-19 shots in development will not protect against this variant, known as the B.1.1.7 lineage.

REUTERS

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here